CN106491928A - A kind of Synergistic treatment brachia plexus injury type cerebral palsy composite preparation - Google Patents

A kind of Synergistic treatment brachia plexus injury type cerebral palsy composite preparation Download PDF

Info

Publication number
CN106491928A
CN106491928A CN201611143566.5A CN201611143566A CN106491928A CN 106491928 A CN106491928 A CN 106491928A CN 201611143566 A CN201611143566 A CN 201611143566A CN 106491928 A CN106491928 A CN 106491928A
Authority
CN
China
Prior art keywords
parts
maifanitum
composite preparation
cerebral palsy
synergistic treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611143566.5A
Other languages
Chinese (zh)
Inventor
于希萌
蔡冬
马文静
韩晨
张洪瑜
于子洋
刘凤仪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Haicheng Intellectual Property Services Co Ltd
Original Assignee
Qingdao Haicheng Intellectual Property Services Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Haicheng Intellectual Property Services Co Ltd filed Critical Qingdao Haicheng Intellectual Property Services Co Ltd
Priority to CN201611143566.5A priority Critical patent/CN106491928A/en
Publication of CN106491928A publication Critical patent/CN106491928A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486—Millettia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/758—Zanthoxylum, e.g. pricklyash
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to Chinese medicine formula technical field, is related to a kind of Synergistic treatment brachia plexus injury type cerebral palsy composite preparation, its formula is：Pheretima (parched), Ramulus Mori, Ramulus Cinnamomi, Rhizoma Chuanxiong, Caulis Spatholobi, the Radix Astragali, the Radix Paeoniae Alba, Folium Zanthoxyli Bungeani, mentha leave, dry Bulbus Allii Fructus Citri tangerinae, Semen Ginkgo shell, Pericarppium arachidis hypogaeae, Maifanitum and Sal；Processing step is：Composite preparation raw material and Maifanitum are put into immersion in pure water, then slow fire digestion 40～60 minutes after big fire digestion, solids removed by filtration medicinal residues obtain final product Synergistic treatment children with spastic composite preparation；During use, Maifanitum is taken out and is put in the preferable Fructus Jujubae wood container of heat insulating ability simultaneously with fluid composition preparation；Again the body part patient except a head part be put into Fructus Jujubae wood container, daily bathing 1～2 time, 30～40 minutes every time, maintain the circulation of air during bathing, life-time service contributes to preventing and treating brain diseasess, its formula combination ratio science, have no toxic side effect, with preventing and curing diseases and bathing multi-efficiency.

Description

A kind of Synergistic treatment brachia plexus injury type cerebral palsy composite preparation
Technical field：
The invention belongs to Chinese medicine formula technical field, it is related to one kind natural plants and is combined into for being reached by bathing mode To the bathing agent prescription prevented and treated by disease of brain, particularly a kind of Synergistic treatment brachia plexus injury type cerebral palsy compositionss system Agent.
Background technology：
It is health care and the important medical mode of antiseptical that bathing is carried out using pharmaceutical preparation, is flowed in the developing history of China in a steady stream Long, existing more than 3000 years applicating history.Modern medicine has carried out deep excavation and popularization to ancient medicinal bath therapy, obtains Gratifying achievement；Traditional Chinese medicine medicated bath belongs to external treatment with Chinese medicine law areas, also adheres to the original of motherland's medical science determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs as oral medicine Then.Dipping refers to that the medicine of suitable health care is put into gauze bag is put into decoction in water, then makes bath agent, then mixes hot water Middle shower, to reach health care and disease cure, allaying tiredness, constitutional effect.The various baths that is made using natural plants and Chinese medicine Agent can pass through skin barrier, play gas and meridians, harmonizing yingfen and weifen, hard masses softening and resolving, promoting blood circulation to remove obstruction in the collateral, antalgic, expelling wind and cold and Removing damp-heat etc. is acted on；Modern pharmacology research shows that dipping also has expansion of blood vessels, increases systemic blood flow, reduces blood pressure With Blood denseness, reduce platelet aggregation, improve microcirculation and accelerate metabolic effect.At present, dipping is divided into local With two kinds of whole body bathing, whole body dipping is that medication immersion steeps other positions of whole body in addition to incidence, and its active area is bigger, medicine Availability is high；Local dipping is to directly act on flesh table muscle and joint by medicine, is directed to disease position, the cause of disease and plays treatment Effect, improves skin, muscle and joint metabolism, recovers its normal function for preventing and treating position.
Cerebral palsy habituation abbreviation cerebral palsy, its cause of disease are considerably complicated, are commonly divided into two kinds of heritability and Secondary cases, mesh Spasm type (spastic), dyskinetic can be substantially divided into using Minear typings according to clinical symptoms more than front (dyskinetic), ataxia type (ataxic) and mixed type (mixed)；The treatment of cerebral palsy diseases is a synthesis , omnibearing, very long and incremental rehabilitation course, while Drug therapy, typically need physiotherapy, rehabilitation The integrated application of the method such as training, Drug therapy and operative treatment or stem cell transplantation, including PT (physiotherapy), OT (occupational therapy), ST (language therapy), sensation feature extraction, Montessori education, conductive education, early intervention, orthopedic The present medical treatments such as tool, nerve electric stimulation treatment and botulinum toxin injection art, also include Chinese medicine acupuncture, massage, dipping, wax Treatment, cup, acupoint injection therapy and meridians lead the multiple tcm therapies of equality, and herbal treatment can also be aided in and hyperbaric oxygen therapy, medicine and handss Art coordinates to be carried out.The dipping therapeutic modality of department of pediatrics brain disease also rises, more delicate for child skin, easily absorbs Medicine, and which is difficult to the features such as coordinating to conventional treatment regime, the therapeutic domain of dipping, pharmacological action and curative effect is carried out deeply Research and inquirement, the dipping preparation for cerebral palsy sick child application are also constantly being pushed away newly.At present, the formula of dipping preparation has a lot, China Patent 200410022705.X discloses one kind and treats cerebral palsy hydrocephaluss pure Chinese herbal medicine foot bathing lotion, by Rhizoma Gastrodiae, shell, Portunustrituberculatuss, wears Filter through low baking temperature infusion and obtain after the mixing of the raw material such as Squama Manis and Fructus Lycii；Chinese patent 200710054966.3 discloses a kind of immersion The Chinese herbal and crude drugs preparationses for the treatment of cerebral palsy, it is that totally 20 taste Chinese herbal medicine are matched somebody with somebody by Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Radix Achyranthis Bidentatae, Herba Cistanches, Fructus Chaenomeliss and Rhizoma Homalomenae etc. System is formed, and there is energetically therapeutic effect to person in middle and old age's cerebral palsy, but, Chinese medicine and non-Chinese medicine natural plants are mixed and made into medicine Dipping preparation also more rare, therefore, design a kind of Synergistic treatment arm being mixed by Chinese medicine and non-Chinese medicine natural plants Clump nerve injury type cerebral palsy composite preparation has prospect very much,
Content of the invention：
It is an object of the invention to overcoming the shortcoming that prior art is present, effect of Chinese medicine is fully excavated, using existing Coordinated by Chinese medicinal ingredients and planting raw material and constitute Synergistic treatment brachia plexus injury type cerebral palsy composite preparation.
To achieve these goals, Synergistic treatment brachia plexus injury type cerebral palsy composite preparation according to the present invention is matched somebody with somebody Fang Wei：10～15 parts of Pheretima (parched), 15～20 parts of Ramulus Mori, 20～30 parts of Ramulus Cinnamomi, 15～20 parts of Rhizoma Chuanxiong, 20～30 parts of Radix Angelicae Sinensis, Flos Carthami 6 ～10 parts, 15～20 parts of Caulis Spatholobi, 25～30 parts of the Radix Astragali, 15～20 parts of the Radix Paeoniae Alba, 30～40 parts of Folium Zanthoxyli Bungeani, mentha leave 20～30 Part, 50～60 parts of dry Bulbus Allii Fructus Citri tangerinae, 50～60 parts of Semen Ginkgo shell, 30～40 parts of Pericarppium arachidis hypogaeae, 500～700 parts of Maifanitum and Sal 30～ 50 parts.
Synergistic treatment brachia plexus injury type cerebral palsy composite preparation according to the present invention realizes that the processing step for preparing is： Component ratio by weight weighs composite preparation raw material and Maifanitum, and composite preparation raw material mix homogeneously is obtained mixed material, will Mixed material and Maifanitum are put in 40～60 DEG C of pure water simultaneously and soak 0.5～1 hour, wherein mixed material total amount with pure The proportion of water is 1:10～40, then big fire digestion slow fire digestion 40～60 minutes again to after boiling, solids removed by filtration medicinal residues are Obtain Synergistic treatment brachia plexus injury type cerebral palsy composite preparation；During use, Maifanitum is taken out same with fluid composition preparation When be put in heat insulating ability preferable Fructus Jujubae wood container；Body part patient except a head part is put into Fructus Jujubae wood container, daily bathing 1 again ～2 times, 30～40 minutes every time, water temperature was controlled at 30～38 DEG C, is kept room temperature at 22～24 DEG C, constantly will be mended during bathing Fill the temperature constant of pure water control composition preparation and maintain the circulation of air, life-time service contributes to preventing and treating brain diseasess.
Maifanitum according to the present invention is produced by the underground Maifanitum mining area in Shandong Jimo area, and make a diameter of 5～ The stone of 10cm.
Compared with prior art, its formula material is easy to get the present invention, portfolio ratio science, medicament mature preparation process, prevents Control effect substantially, have no toxic side effect, with preventing and curing diseases and bathing multi-efficiency, balneation environmental friendliness.
Specific embodiment：
The present invention is further illustrated below by embodiment.
Embodiment 1：
The formula of the Synergistic treatment brachia plexus injury type cerebral palsy composite preparation that the present embodiment is related to is：Pheretima (parched) 15 Part, 20 parts of Ramulus Mori, 30 parts of Ramulus Cinnamomi, 20 parts of Rhizoma Chuanxiong, 30 parts of Radix Angelicae Sinensis, 10 parts of Flos Carthami, 20 parts of Caulis Spatholobi, 25 parts of the Radix Astragali, 20 parts of the Radix Paeoniae Alba, 35 parts of Folium Zanthoxyli Bungeani, 25 parts of mentha leave, 55 parts of dry Bulbus Allii Fructus Citri tangerinae, 60 parts of Semen Ginkgo shell, 35 parts of Pericarppium arachidis hypogaeae, 500 parts of Maifanitum and Sal 40 Part.
The composite preparation that the present embodiment is related to realizes that the processing step for preparing is：Component ratio by weight weighs compositionss system Composite preparation raw material mix homogeneously is obtained mixed material by agent raw material and Maifanitum, and mixed material is put into simultaneously with Maifanitum Soak in 40～60 DEG C of pure water 0.5～1 hour, wherein mixed material total amount is 1 with the proportion of pure water:10～40, then greatly Fiery digestion slow fire digestion 40～60 minutes again to after boiling, solids removed by filtration medicinal residues obtain final product Synergistic treatment brachia plexus injury type Cerebral palsy composite preparation；During use, Maifanitum is taken out and the preferable Fructus Jujubae wood appearance of heat insulating ability is put into simultaneously with fluid composition preparation In device；Again the body part patient except a head part be put into Fructus Jujubae wood container, daily bathing 1～2 time, 30～40 minutes every time, water Temperature control system is kept room temperature at 22～24 DEG C, will be continuously replenished pure water control composition system during bathing at 30～38 DEG C The temperature constant of agent simultaneously maintains the circulation of air, and life-time service contributes to preventing and treating brain diseasess.The Maifanitum that the present embodiment is related to by The underground Maifanitum mining area in Shandong Jimo area produces, and makes the stone of a diameter of 5～10cm.
Embodiment 2：
The present embodiment difference from Example 1 is matching somebody with somebody for Synergistic treatment brachia plexus injury type cerebral palsy composite preparation Fang Wei：10 parts of Pheretima (parched), 15 parts of Ramulus Mori, 25 parts of Ramulus Cinnamomi, 15 parts of Rhizoma Chuanxiong, 25 parts of Radix Angelicae Sinensis, 8 parts of Flos Carthami, 18 parts of Caulis Spatholobi, the Radix Astragali 28 Part, 15 parts of the Radix Paeoniae Alba, 30 parts of Folium Zanthoxyli Bungeani, 20 parts of mentha leave, 50 parts of dry Bulbus Allii Fructus Citri tangerinae, 55 parts of Semen Ginkgo shell, 30 parts of Pericarppium arachidis hypogaeae, Maifanitum 600 parts and 30 parts of Sal；Its preparation technology and using method are with embodiment 1.Nanjing hospital chooses brachia plexus injury type Cerebral palsy patient 20, with Synergistic treatment brachia plexus injury type cerebral palsy composite preparation manufactured in the present embodiment and its use Method, adhered to using 6 months, and through examination in hospital, brain has development or takes a turn for the better, and quadruped locomotion motility increases, explanation This product has functions that auxiliary treatment brain is paralysed.
Embodiment 3：
The present embodiment difference from Example 1 is matching somebody with somebody for Synergistic treatment brachia plexus injury type cerebral palsy composite preparation Fang Wei：13 parts of Pheretima (parched), 17 parts of Ramulus Mori, 20 parts of Ramulus Cinnamomi, 18 parts of Rhizoma Chuanxiong, 20 parts of Radix Angelicae Sinensis, 6 parts of Flos Carthami, 15 parts of Caulis Spatholobi, the Radix Astragali 30 Part, 18 parts of the Radix Paeoniae Alba, 40 parts of Folium Zanthoxyli Bungeani, 30 parts of mentha leave, 60 parts of dry Bulbus Allii Fructus Citri tangerinae, 50 parts of Semen Ginkgo shell, 40 parts of Pericarppium arachidis hypogaeae, Maifanitum 700 parts and 50 parts of Sal；Its preparation technology is with embodiment 1；Synergistic treatment brachia plexus injury type cerebral palsy manufactured in the present embodiment Composite preparation also has the flexible function for strengthening blood capillary and constitutional effect, and there is auxiliary to cerebral concussion patients Therapeutic effect.
Embodiment 4：
The present embodiment selects Synergistic treatment brachia plexus injury type cerebral palsy composite preparation prepared by embodiment 1, chooses 20 The brain diseasess patient for causing is not treated in time because of meningitiss in position, is divided into two groups, and one group carries out auxiliary using this product and controls Treat, with embodiment 1, another group is not used this product to using method, and other treatment is identical；Through the auxiliary treatment of 7 months, using this One group of product is fast than one group of brain improvement speed of unused this product, and therefore, this product is to causing because of meningitiss etc. Brain diseasess have adjuvant treatment effect.

Claims (2)

1. a kind of Synergistic treatment brachia plexus injury type cerebral palsy composite preparation, it is characterised in that formula is：Pheretima (parched) 10～15 Part, 15～20 parts of Ramulus Mori, 20～30 parts of Ramulus Cinnamomi, 15～20 parts of Rhizoma Chuanxiong, 20～30 parts of Radix Angelicae Sinensis, 6～10 parts of Flos Carthami, Caulis Spatholobi 15～ 20 parts, 25～30 parts of the Radix Astragali, 15～20 parts of the Radix Paeoniae Alba, 30～40 parts of Folium Zanthoxyli Bungeani, 20～30 parts of mentha leave, dry Bulbus Allii Fructus Citri tangerinae 50～60 30～50 parts of part, 50～60 parts of Semen Ginkgo shell, 30～40 parts of Pericarppium arachidis hypogaeae, 500～700 parts of Maifanitum and Sal；Its concrete technology step Suddenly it is：Component ratio by weight weighs composite preparation raw material and Maifanitum, and composite preparation raw material mix homogeneously must be mixed original Mixed material and Maifanitum are put into immersion 0.5～1 hour, wherein mixed material total amount in 40～60 DEG C of pure water by material simultaneously Proportion with pure water is 1:10～40, then big fire digestion slow fire digestion 40～60 minutes again to after boiling, solids removed by filtration Medicinal residues obtain final product Synergistic treatment brachia plexus injury type cerebral palsy composite preparation；During use, Maifanitum is taken out and fluid composition Preparation is put in the preferable Fructus Jujubae wood container of heat insulating ability simultaneously；Body part patient except a head part is put into Fructus Jujubae wood container again, per Day bathing 1～2 time, 30～40 minutes every time, water temperature was controlled at 30～38 DEG C, kept room temperature at 22～24 DEG C, during bathing The temperature constant of pure water to be continuously replenished control composition preparation simultaneously maintains the circulation of air, and life-time service contributes to preventing and treating brain Portion's disease.
2. Synergistic treatment brachia plexus injury type cerebral palsy composite preparation according to claim 1, it is characterised in that described Maifanitum produced by the underground Maifanitum mining area in Shandong Jimo area, and make the stone of a diameter of 5～10cm.
CN201611143566.5A 2016-12-13 2016-12-13 A kind of Synergistic treatment brachia plexus injury type cerebral palsy composite preparation Pending CN106491928A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611143566.5A CN106491928A (en) 2016-12-13 2016-12-13 A kind of Synergistic treatment brachia plexus injury type cerebral palsy composite preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611143566.5A CN106491928A (en) 2016-12-13 2016-12-13 A kind of Synergistic treatment brachia plexus injury type cerebral palsy composite preparation

Publications (1)

Publication Number Publication Date
CN106491928A true CN106491928A (en) 2017-03-15

Family

ID=58329829

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611143566.5A Pending CN106491928A (en) 2016-12-13 2016-12-13 A kind of Synergistic treatment brachia plexus injury type cerebral palsy composite preparation

Country Status (1)

Country Link
CN (1) CN106491928A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107669787A (en) * 2017-11-08 2018-02-09 尚云 A kind of Chinese medicine body lotion for treating neonate's brachial plexus paralysis
CN107952011A (en) * 2017-12-25 2018-04-24 青岛市妇女儿童医院 A kind of dipping preparation of auxiliary treatment brachia plexus injury
CN108030878A (en) * 2017-12-25 2018-05-15 青岛市妇女儿童医院 A kind of dipping preparation of auxiliary treatment cerebral palsy
CN116211989A (en) * 2023-05-06 2023-06-06 首都医科大学附属北京儿童医院 Traditional Chinese medicine bath lotion matched with rehabilitation for treating childbirth brachial plexus injury

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101112474A (en) * 2007-08-15 2008-01-30 吕卫荣 Chinese herbal medicine preparations for treating cerebral pasly through immersion
CN101780145A (en) * 2010-03-26 2010-07-21 秦彩玲 Medical stone mineral health-care product
CN102018941A (en) * 2009-09-17 2011-04-20 北京联合大学 Chinese medicinal composition for treating children spastic cerebral paralysis
CN102772434A (en) * 2012-08-20 2012-11-14 山西中远威药业有限公司 Application and preparation method of medicament and functional food for treating brain paralysis
CN104547009A (en) * 2015-01-12 2015-04-29 陈著荣 Traditional Chinese medicine composition for treating cerebral palsy as well as preparations and preparation method of traditional Chinese medicine composition

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101112474A (en) * 2007-08-15 2008-01-30 吕卫荣 Chinese herbal medicine preparations for treating cerebral pasly through immersion
CN102018941A (en) * 2009-09-17 2011-04-20 北京联合大学 Chinese medicinal composition for treating children spastic cerebral paralysis
CN101780145A (en) * 2010-03-26 2010-07-21 秦彩玲 Medical stone mineral health-care product
CN102772434A (en) * 2012-08-20 2012-11-14 山西中远威药业有限公司 Application and preparation method of medicament and functional food for treating brain paralysis
CN104547009A (en) * 2015-01-12 2015-04-29 陈著荣 Traditional Chinese medicine composition for treating cerebral palsy as well as preparations and preparation method of traditional Chinese medicine composition

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107669787A (en) * 2017-11-08 2018-02-09 尚云 A kind of Chinese medicine body lotion for treating neonate's brachial plexus paralysis
CN107952011A (en) * 2017-12-25 2018-04-24 青岛市妇女儿童医院 A kind of dipping preparation of auxiliary treatment brachia plexus injury
CN108030878A (en) * 2017-12-25 2018-05-15 青岛市妇女儿童医院 A kind of dipping preparation of auxiliary treatment cerebral palsy
CN116211989A (en) * 2023-05-06 2023-06-06 首都医科大学附属北京儿童医院 Traditional Chinese medicine bath lotion matched with rehabilitation for treating childbirth brachial plexus injury

Similar Documents

Publication Publication Date Title
CN106491928A (en) A kind of Synergistic treatment brachia plexus injury type cerebral palsy composite preparation
CN101002915B (en) Soaking type traditional Chinese medicine for treating chilblain, and its preparing method
CN106110216A (en) Treat neurasthenic Chinese medicinal formulae
CN104784614A (en) Traditional Chinese medicine composition for treating kidney deficiency
CN104547093A (en) Traditional Chinese medicine composition for treating tenosynovitis
CN106728746A (en) A kind of Synergistic treatment children with spastic composite preparation
CN103830672A (en) Traditional Chinese medicine for treating scapulohumeral periarthritis
CN104162088A (en) Traditional Chinese medicine composition for relieving rigidity of muscles, activating collaterals and eliminating dampness and preparation method thereof
CN103721082A (en) Traditional Chinese medicinal composition for treating scapulohumeral periarthritis
CN103520289B (en) A kind of Chinese medicine composition for the treatment of constipation and its preparation method and application
CN105617198A (en) Method for preparing medicinal liquor for treating wind-cold low back pain
CN101530598B (en) Plaster used for hyperosteogeny
CN103735829A (en) Traditional Chinese medicine composition for treating spontaneous perspiration
CN104127513A (en) Medicine for treating localized scleroderma
CN103751418A (en) Traditional Chinese medicine composition for treating restless leg syndrome
CN101953999B (en) Medicinal composition for treating paralysis and preparation method thereof
CN103690833B (en) A kind of Chinese medicine for the treatment of rheumatic arthritis
CN103800618B (en) A kind of oral administration pills and preparation method thereof for the treatment of waist leg joint pain
CN102861220A (en) Traditional Chinese medicine for treating heart disease
CN101264225B (en) Orally-administered decoction for treating ulcer in tongue base
CN106075137A (en) A kind of Chinese medicine composition treating hysteria
Li Observations on the Therapeutic Effect of Point-Through-Point Acupuncture Plus Chinese Herbal Medicine on Intractable Hiccup in Tumor Patients.
CN104248689A (en) Traditional Chinese medicine for treating female sexual hypoactivity
CN103041187B (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis by oral medication
CN104001115A (en) Traditional Chinese medicine for treating hands and feet numbness

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170315

RJ01 Rejection of invention patent application after publication